Duopharma Biotech Berhad

KLSE:DPHARMA Stock Report

Market Cap: RM 1.2b

Duopharma Biotech Berhad Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DPHARMA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,999,1240.312%
Private Companies15,068,7981.57%
General Public253,053,70626.3%
Institutions690,820,82371.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 73.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
50.9%
Permodalan Nasional Berhad
489,286,904RM 606.7m0%0.36%
8.69%
Employees Provident Fund of Malaysia
83,639,911RM 103.7m2.96%0.05%
4%
Lembaga Tabung Haji, Endowment Arm
38,499,554RM 47.7m0%0.35%
2.17%
Eastspring Investments (Singapore) Limited
20,882,493RM 25.9m0%0.02%
1.57%
Billion Victory Sdn Bhd
15,068,798RM 18.7m0%no data
1.18%
Hong Leong Asset Management Bhd.
11,331,000RM 14.1m0%0.4%
1.06%
Public Mutual Bhd.
10,226,597RM 12.7m0%0.07%
0.99%
Norges Bank Investment Management
9,556,800RM 11.9m0%no data
0.55%
Bank Negara Malaysia National Trust Fund
5,287,100RM 6.6m0%1.33%
0.52%
Amanah Raya Investment Management Sdn Bhd
4,958,000RM 6.1m0%1.2%
0.4%
Syarikat Takaful Malaysia Bhd, Asset Management Arm
3,860,900RM 4.8m0%31.33%
0.38%
Dimensional Fund Advisors LP
3,651,343RM 4.5m-0.03%no data
0.36%
Meridian Asset Management Sdn Bhd
3,432,089RM 4.3m0%2.73%
0.3%
Tan Keng Ooi
2,900,909RM 3.6m0%no data
0.28%
Manulife Investment Management (M) Bhd.
2,670,211RM 3.3m0%0.54%
0.25%
Kenanga Investors Bhd.
2,436,000RM 3.0m0%0.06%
0.058%
AmIslamic Funds Management Sdn Bhd
561,000RM 695.6k0%0.99%
0.029%
State Street Global Advisors, Inc.
280,291RM 347.6k-1.61%no data
0.026%
TA Investment Management Berhad
250,000RM 310.0k0%0.18%
0.0069%
Su Ng
65,920RM 81.7k0%no data
0.0026%
Mohd Bin Mohd Yunus
25,293RM 31.4k0%no data
0.0011%
American Century Investment Management Inc
10,630RM 13.2k0%no data
0.00042%
Zaini Bin Said
4,000RM 5.0k0%no data
0.0003%
Krisnakumara Reddi
2,878RM 3.6k0%no data
0.00001%
Wu Chek
124RM 119.30%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 18:28
End of Day Share Price 2025/01/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Duopharma Biotech Berhad is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hsien Jin LamCGS International
Kenneth LeongMalacca Securities Sdn Bhd
Norfauzi Bin NasronOSK-DMG